Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Oteseconazole (VT-1161) is an orally active anti-fungal agent. Oteseconazole displays no obvious effect on human CYP51. It also potently binds to and inhibits Candida albicans CYP51 (Kd, <39 nM).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 116.00 | |
5 mg | In stock | $ 289.00 | |
10 mg | In stock | $ 455.00 | |
25 mg | In stock | $ 822.00 | |
50 mg | In stock | $ 1,370.00 | |
100 mg | In stock | $ 1,830.00 | |
200 mg | In stock | $ 2,480.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 335.00 |
Description | Oteseconazole (VT-1161) is an orally active anti-fungal agent. Oteseconazole displays no obvious effect on human CYP51. It also potently binds to and inhibits Candida albicans CYP51 (Kd, <39 nM). |
Synonyms | VT-1161 |
Molecular Weight | 527.39 |
Formula | C23H16F7N5O2 |
CAS No. | 1340593-59-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 250 mg/mL (474.03 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Oteseconazole 1340593-59-0 Metabolism Microbiology/Virology P450 Antifungal Fungal inhibit VT1161 VT-1161 VT 1161 Cytochrome P450 CYPs Inhibitor inhibitor